Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age

NCT01975012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Rilpivirine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]